Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort
Journal of Internal Medicine · 2026
DOI: 10.1111/joim.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Oumarou Nabi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Fatty Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Swedish Research Council.
Abstract (Originalsprache)
Background and Aims Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population cohort. Methods From the Swedish CArdioPulmonary bioImage Study (SCAPIS) cohort, we analyzed 27,763 participants aged 50–64 years who underwent extensive clinical characterization. MASLD was defined as
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden.
- Department of Clinical Physiology, Västra Götalandsregionen, Gothenburg, Sweden.
- Department of Clinical Science in Malmö, Lund University, Lund, Sweden.
- Department of Health, Medicine and Caring and Sciences, Linköping University, Linköping, Sweden.
ORCID-Profile: Oumarou Nabi, Göran Bergström, Andrei Malinovschi, Daniel P Andersson, Hannes Hagström
Förderung
- The Swedish Research Council
Zitieren
APA
Nabi, O., Spaak, J., Bergström, G., Engström, G., Johan Östgren, C., Malinovschi, A., Kullberg, J., Blomberg, A., Jernberg, T., Andersson, D. P., & Hagström, H. (2026). Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. Journal of Internal Medicine. https://doi.org/10.1111/joim.70071
Vancouver
Nabi O, Spaak J, Bergström G, Engström G, Johan Östgren C, Malinovschi A, et al. Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort. Journal of Internal Medicine. 2026. doi:10.1111/joim.70071
BibTeX
@article{Nabi2026,
author = {Nabi, Oumarou and Spaak, Jonas and Bergström, Göran and Engström, Gunnar and Johan Östgren, Carl and Malinovschi, Andrei and Kullberg, Joel and Blomberg, Anders and Jernberg, Tomas and Andersson, Daniel P and Hagström, Hannes},
title = {Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort},
journal = {Journal of Internal Medicine},
year = {2026},
doi = {10.1111/joim.70071}
}
EUVIMED